latest news in Pharmaceutical merger

Aytu BioPharma to Be Acquired in $56 Million Cash Deal

Aytu BioPharma to Be Acquired in $56 Million Cash Deal

Denver, Monday, 16 November 2026.
Alongside reporting a 6.9% quarterly revenue increase, Aytu BioPharma agreed to a $56 million buyout by Rosemont Pharmaceuticals, canceling its earnings call to finalize the acquisition.